A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age22+
SponsorUroMems SAS

About this trial

Prospective, multicenter, single-arm study

Eligibility criteria

Qualifiers

Male subjects aged ≥ 22 years old

Able to read, comprehend and willing to sign an informed consent form

Primary diagnosis of stress urinary incontinence for at least 6 months, as assessed by the investigator

Appropriate surgical candidate with no medical or mental condition that would interfere with study procedures or confound study outcomes as assessed by the investigator

Disqualifiers

Currently enrolled or plans to enroll in another investigational device or clinical drug trial or has completed an investigational study (for urinary incontinence) in the past 3 months prior to informed consent

Poor candidate for surgical procedures and/or anesthesia, as determined by investigator

Currently implanted with an Active Implantable Medical Device (AIMD)

Symptoms or diagnosis of urge incontinence or mixed incontinence (MI) with a predominant urgency component, as assessed by the investigator

Trial design

Treatments tested in this trial

  • Artificial Urinary Sphincter (AUS)

Treatment groups

140 Participants
are divided into 1 treatment group

Sponsors and collaborators